Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose rabies pre-exposure priming study
NL-OMON24881Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2018
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Rabies vaccine in rabies (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Rate of increase of geometric mean concentrations of neutralizing antibodies from day 0 to day 7 after revaccination. Started May 2018; status: active, not recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NL-OMON24881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24881.